UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 12, 2016
APPLIED GENETIC TECHNOLOGIES CORPORATION
(Exact name of Registrant as Specified in Its Charter)
|
Delaware |
|
001-36370 |
|
59-3553710 |
|
(State or Other Jurisdiction of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
|
|
|
|
14193 NW 119th Terrace Suite 10 Alachua, Florida |
|
|
|
32615 |
|
(Address of Principal Executive Offices) |
|
|
|
(Zip Code) |
Registrant’s Telephone Number, Including Area Code: (386) 462-2204
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. Results of Operations and Financial Condition
On September 12, 2016, Applied Genetic Technologies Corporation issued a press release entitled “AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June 30, 2016.” The press release is furnished as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
Exhibit No. |
Description |
|
99.1 |
Press release dated September 12, 2016, entitled “AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June 30, 2016” |
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
APPLIED GENETIC TECHNOLOGIES CORPORATION |
|
|
|
|
|
|
|
|
Date: September 12, 2016 |
|
By: |
/s/ Lawrence E. Bullock |
|
|
|
|
|
|
Lawrence E. Bullock |
|
|
|
|
|
Chief Financial Officer |
3
|
Exhibit No. |
Description |
|
99.1 |
Press release dated September 12, 2016, entitled “AGTC Announces Financial Results and Business Update for the Quarter and Fiscal Year Ended June 30, 2016” |
4